| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1916387 | Journal of the Neurological Sciences | 2006 | 7 Pages | 
Abstract
												Impaired suppressive function of CD4+CD25high regulatory T cells (Treg) has been reported as a novel pathogenetic mechanism in Multiple sclerosis (MS). We addressed if high apoptosis sensitivity of MS-Treg could explain this functional Treg defect. Treg from treatment-naïve MS patients showed high sensitivity towards CD95Ligand-mediated apoptosis and exhibited enhanced cell death to IL-2 and TCR-signal deprivation. Since susceptibility of Treg to cell death was similar in MS patients and healthy controls, this cannot explain the inhibitory dysfunction of Treg associated with MS. Furthermore, as cell death is not enhanced, therapeutic expansion of MS-Tregin vitro should be a reasonable and novel therapeutic option.
Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Ageing
												
											Authors
												Benedikt Fritzsching, Mirjam Korporal, Jürgen Haas, Peter H. Krammer, Elisabeth Suri-Payer, Brigitte Wildemann, 
											